0001144204-17-011044.txt : 20170224 0001144204-17-011044.hdr.sgml : 20170224 20170224173801 ACCESSION NUMBER: 0001144204-17-011044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170224 FILED AS OF DATE: 20170224 DATE AS OF CHANGE: 20170224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NAVARRO SAMUEL E CENTRAL INDEX KEY: 0001269368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 17638776 MAIL ADDRESS: STREET 1: C/O STRATA SKIN SCIENCES, INC. STREET 2: 100 LAKESIDE DRIVE, SUITE 100 CITY: HORSHAM STATE: PA ZIP: 19044 4 1 v460296_form4.xml FORM 4 X0306 4 2017-02-24 1 0000892160 DERMA SCIENCES, INC. DSCI 0001269368 NAVARRO SAMUEL E C/O CARDICA, INC. 900 SAGINAW DRIVE REDWOOD CITY CA 94063 1 0 0 0 Common Stock 2017-02-24 4 D 0 37500 D 0 D Common Stock 2017-02-24 4 D 0 25000 A 25000 D Restricted Stock Units 2017-02-24 4 D 0 25000 0 D Common Stock 25000 0 D Pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2017, by and among the Issuer, Integra Derma, Inc. and Integra LifeSciences Holdings Corporation (the "Merger Agreement"), as of the Effective Time (as defined in the Merger Agreement), the shares of the Issuer's common stock were converted into the right to receive $7.00 per share to the reporting person in cash. Represents shares of the Issuer's common stock received upon the vesting of 25,000 restricted stock units, as described herein. Upon the Effective Time, and in connection with a tender offer pursuant to which Integra Derma, Inc. offered to purchase all of the Issuer's common stock for $7.00 per share, the restricted stock units were converted into the right to receive an amount in cash equal to $7.00 with respect to each share of common stock underlying such award, payable without any interest thereon and subject to any required tax withholdings. The restricted stock units were originally granted in consideration of the reporting person's services to the Issuer and without payment of consideration. /s/ Samuel E. Navarro 2017-02-24